1715 — AI Health Technology Balance Sheet
0.000.00%
- HK$187.60m
- HK$194.41m
- CNY91.89m
Annual balance sheet for AI Health Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 48.2 | 32.3 | 11.4 | 34 | 2.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 59.7 | 32.2 | 19.2 | 39.4 | 31.1 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 195 | 151 | 167 | 135 | 118 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 23.6 | 22.4 | 16.2 | 14.4 | 10.2 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 246 | 191 | 194 | 166 | 137 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 66 | 60.2 | 109 | 102 | 88.5 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 77.6 | 66.5 | 113 | 108 | 95.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 169 | 124 | 80.4 | 58.2 | 42.1 |
| Total Liabilities & Shareholders' Equity | 246 | 191 | 194 | 166 | 137 |
| Total Common Shares Outstanding |